Clinical trial · Observational
Lay Health Worker Led Symptom Assessment Intervention
Joint Oncology Collaboration for Proactive Symptom Assessments by a Lay Health Worker
NCT03737058CI-TRIAL-00086520completedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Rising costs and poor patient experiences from under-treated symptoms have led to the demand for approaches that improve patients' experiences and lower expenditures. This observational project assigned a lay health worker to conduct proactive symptom assessments intended to achieve these goals among patients with advanced cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Program participants | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Edmonton Symptom Assessment Scale Score (ESAS)
- timeFrame
- 12 months after patient enrollment
- description
- ESAS measures participant responses to 10 common symptoms (pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath, appetite, sleep problems, and feeling of well-being). Participants rate the intensity of 10 symptoms, each on a 11-point scale (0 to 10); sub-scores are then summed and averaged to create a total symptom score (range: 0 to 10, with 10 corresponding to worst symptom severity).
Secondary outcomes (5)
- measure
- Incidence of Emergency Department Visits
- timeFrame
- 12 months after patient enrollment
- description
- Emergency Department use for each patient abstracted from medical claims data review for each patient at 12 months after enrollment.
- measure
- Hospitalization Visits (Claims Review)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Clinical diagnosis of stage 3 and 4 cancer 2. Clinical diagnosis of hematologic malignancy 3. Must receive care at the Oncology Institute of Hope and Innovation 4. Must be an enrollee of CareMore Medicare Advantage Exclusion Criteria: None
References
Publications (0)
Data not yet available
No reference posted for this study.